II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance

Scandinavian Journal of Infectious Diseases, Supplement

Volumn , Issue 105, 1997, Pages 8-12

  Ringertz, Signe ^a   Olsson Liljequist, Barbro ^b   Kahlmeter, Gunnar ^c   Kronvall, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; PENICILLIN G; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; SWEDEN; BACTERIAL INFECTION; DIAGNOSTIC ERROR; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PRACTICE GUIDELINE; REVIEW; STANDARD;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DIAGNOSTIC ERRORS; DRUG RESISTANCE, MICROBIAL; GUIDELINES; MICROBIAL SENSITIVITY TESTS; SWEDEN;

EID: 0031304471     PISSN: 03008878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Olsson-Liljequist B, Forsgren A. Antimicrobial susceptibility testing in Sweden. I. The work of the Swedish Reference Group for Antibiotics (SRGA and SRGA-M). Scand J Infect Dis Suppl 105: 5-7, 1997.
2. Swedish Reference Group for Antibiotics. A revised system for antibiotic sensitivity testing. Scand J Infect Dis 13: 148-152, 1981.
3. Krasemann C, Hildenbrand G. Interpretation of agar diffusion tests. J Antimicrob Chemother 6: 181-187, 1980.
4. Dickert H, Machka K, Braveny I. The uses and limitations of disc diffusion in the antibiotic sensitivity testing of bacteria. Infection 9: 18-24, 1981.
5. Ringertz S, Olsson-Liljequist B, Kronvall G. Antimicrobial susceptibility testing of Haemophilus influenzae: improvement of accuracy of the disc diffusion test. J Antimicrob Chemother 26: 479-489, 1990.
6. Barry AL. Definition of terms 'resistant' and 'susceptible'. In: Barry AL. The antimicrobic susceptibility test: principles and practices. Philadelphia: Lea & Febiger, 12-29, 1976.
7. British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. Report of the working party on antibiotic sensitivity testing of the BSAC. J Antimicrob Chemother 27 (Suppl D) 1991.
8. Soussy CJ, Cluzel R, Courvalin P, Comité de l'Antibiogramme de la Société Francaise de Microbiologie. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. Eur J Clin Microbiol Infect Dis 13: 238-246, 1994.
9. Olsson-Liljequist B, Larsson P, Walder M, Miörner H. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis Suppl 105: 13-23, 1997.
10. Ericsson H, Sherris JC. Antibiotic sensitivity testing. Report of an International Collaborative Study. Acta Pathol Microbiol Scand (Sect B) Suppl 217, 1971.
11. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbial Rev 3: 171-196, 1990.
12. Ringertz S, Rylander M, Kronvall G. Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae. J Clin Microbiol 29: 1604-1609, 1991.
13. Grimard D, Bergeron MG. False-resistance of Streptococcus faecalis and Pseudomonas maltophilia to norfloxacin by disc diffusion susceptibility testing. J Antimicrob Chemother 16: 132-133, 1985.
14. Wiedemann B, Machka K, Malottke R. Multi-center study of the sensitivity of Pseudomonas aeruginosa to antimicrobial agents. Eur J Clin Microbiol 4: 229-230, 1985.
15. Björklind A, Ringertz S, Kronvall G. Types of interpretive errors in susceptibility testing. Zone breakpoints for norfloxacin disk diffusion testing. APMIS 97: 941-948, 1989.
16. Ringertz S, Björklind A, Kronvall G. Species-specific interpretive breakpoints for ciprofioxacin disk diffusion susceptibility testing. Scand J Infect Dis Suppl 60: 46-53, 1989.
17. Kahlmeter G, Olsson-Liljequist B, Ringertz S. Antimicrobial susceptibility testing in Sweden. IV. Quality assurance. Scand J Infect Dis Suppl 105: 24-31, 1997.
18. Spratt BG. Resistance to betalactam antibiotics mediated by alterations of penicillin binding proteins. In: Bryan LE, ed. Microbial resistance to drugs. Springer, Berlin: 77-100, 1989.
19. Chopra I, Hawkey PM, Hinton M. Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother 29: 245-277, 1977.
20. Sanders CC. A problem with antimicrobial susceptibility tests. For the sake of clinical labs and new drug development, such tests should emphasize antibiotic resistance. ASM News 57: 187-190, 1991.
21. Courvalin P. Interpretive reading of antimicrobial susceptibility tests. Molecular analysis and therapeutic interpretation of in vitro tests to improve antibiotic therapy. ASM News 58: 368-375, 1992.
22. Tenover FC. Bauer and Kirby meet Watson and Crick. Antimicrobial susceptibility testing in the molecular era. ASM News 58: 669-672, 1992.
23. Klugman KP, Friedland IR. Antibiotic-resistant pneumococci in pediatric disease. Microbial Drug Resistance 1: 5-8, 1995.